SCHEMBL19412232

SCHEMBL19412232

NC[C@@H](C(=O)O)N(C(=O)[C@@H]1CCCN1)S(=O)(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSC P53634 2/20 0.39
SCN4A P35499 1/20 0.39
KMT2A Q03164 2/20 0.34
ELANE P08246 1/20 0.34
HTR6 P50406 2/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
WNT3 P56703 2/20 0.33
SFRP1 Q8N474 2/20 0.33
CAMK2A Q9UQM7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3113683 0.89 CTSC (0.47) CTSCSCN4AKMT2AHTR2CHTR2B
SCHEMBL3113689 0.89 CTSC (0.47) CTSCSCN4AKMT2AHTR2CHTR2B
SCHEMBL19412130 0.87 CTSC (0.37) CTSCSCN4AKMT2AHTR2CHTR2B
SCHEMBL19412214 0.84 CTSC (0.37) CTSCSCN4AHTR6HTR2CHTR2B
SCHEMBL19412253 0.82 CTSC (0.34) CTSCSCN4AHTR2CHTR2BALDH1A1
SCHEMBL6429094 0.81 CTSC (0.37) CTSCSCN4AKMT2AHTR6ADAMTS5
SCHEMBL19412225 0.81 PRCP (0.34) CTSCSCN4AHTR2CHTR2BALDH1A1
SCHEMBL19412165 0.81 PRCP (0.34) CTSCSCN4AHTR2CHTR2BALDH1A1
SCHEMBL19412177 0.79 CTSC (0.33) CTSCSCN4AHTR2CHTR2BKDM4E
SCHEMBL27565204 0.78 CTSC (0.47) CTSCSCN4AELANEHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3436046-A2 INHIBITORS OF INTEGRIN ALPHA 5 BETA 1 AND METHODS OF USE The Regents of The University of California (US) 2019-02-06 EP disclosed
WO-2017173302-A2 INHIBITORS OF INTEGRIN ALPHA 5 BETA 1 AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-10-05 WO disclosed